| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,* Division of Molecular Pathology, and the Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; the Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts; and the Department of Cell Biology, Harvard Medical School, Boston, Massachusetts
p63, a member of the p53 gene family, encodes multiple proteins that may either transactivate p53 responsive genes (TAp63) or act as a dominant-negative factor toward p53 and p73 (
Np63). p63 is expressed in many epithelial compartments and p63-/- mice fail to develop skin, prostate, and mammary glands among other defects. It has been previously shown that p63 is expressed in normal urothelium. This study reports that p63 is regulated in bladder carcinogenesis and that p63 expression is lost in most invasive cancers whereas papillary superficial tumors maintain p63 expression. Examination of bladder carcinoma cell lines reveals that certain lines derived from invasive carcinomas maintain expression of Np63, as demonstrated by both immunoblotting and confirmed by isoform-specific quantitative reverse transcriptase-polymerase chain reaction. Another novel finding reported in this study is the fact that p63-/- mice develop a bladder mucosa epithelial layer yet fail to complete uroepithelial differentiation, producing a nontransitional default cuboidal epithelium. These data indicate that in contrast to the skin and prostate, p63 is not required for formation of a bladder epithelium but is indispensable for the specific differentiation of a transitional urothelium.
This article has been cited by other articles:
 |
|
 |
|
  H. Fukushima, F. Koga, S. Kawakami, Y. Fujii, S. Yoshida, E. Ratovitski, B. Trink, and K. Kihara Loss of {Delta}Np63{alpha} Promotes Invasion of Urothelial Carcinomas via N-Cadherin/Src Homology and Collagen/Extracellular Signal-Regulated Kinase Pathway Cancer Res., December 15, 2009; 69(24): 9263 - 9270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kommagani, M. K. Leonard, S. Lewis, R.-A. Romano, S. Sinha, and M. P. Kadakia Regulation of VDR by {Delta}Np63{alpha} is associated with inhibition of cell invasion J. Cell Sci., August 15, 2009; 122(16): 2828 - 2835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, M. J. Peart, and C. Prives Stxbp4 Regulates {Delta}Np63 Stability by Suppression of RACK1-Dependent Degradation Mol. Cell. Biol., July 15, 2009; 29(14): 3953 - 3963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Bertagnolli, G. D. Cassali, M. C. L. S. Genelhu, F. A. Costa, J. F. C. Oliveira, and P. B. D. Goncalves Immunohistochemical Expression of p63 and {Delta}Np63 in Mixed Tumors of Canine Mammary Glands and Its Relation with p53 Expression Veterinary Pathology, May 1, 2009; 46(3): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Dhillon, M. Barry, M. J. Stampfer, S. Perner, M. Fiorentino, A. Fornari, J. Ma, J. Fleet, T. Kurth, M. A. Rubin, et al. Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Pearson, T. J. Phesse, and A. R. Clarke K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse Cancer Res., January 1, 2009; 69(1): 94 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Hallack Neto, S A C Siqueira, F L Dulley, M A Ruiz, D A F Chamone, and J Pereira p63 Protein expression in high risk diffuse large B-cell lymphoma J. Clin. Pathol., January 1, 2009; 62(1): 77 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marchini, M. Marabese, E. Marrazzo, P. Mariani, D. Cattaneo, R. Fossati, A. Compagnoni, R. Fruscio, A. A. Lissoni, and M. Broggini {Delta}Np63 expression is associated with poor survival in ovarian cancer Ann. Onc., March 1, 2008; 19(3): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Barbieri, L. J. Tang, K. A. Brown, and J. A. Pietenpol Loss of p63 Leads to Increased Cell Migration and Up-regulation of Genes Involved in Invasion and Metastasis. Cancer Res., August 1, 2006; 66(15): 7589 - 7597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Koster, S.-L. Lu, L. D. White, X.-J. Wang, and D. R. Roop Reactivation of Developmentally Expressed p63 Isoforms Predisposes to Tumor Development and Progression. Cancer Res., April 15, 2006; 66(8): 3981 - 3986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Helton, J. Zhu, and X. Chen The Unique NH2-terminally Deleted ({Delta}N) Residues, the PXXP Motif, and the PPXY Motif Are Required for the Transcriptional Activity of the {Delta}N Variant of p63 J. Biol. Chem., February 3, 2006; 281(5): 2533 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Signoretti, M. M. Pires, M. Lindauer, J. W. Horner, C. Grisanzio, S. Dhar, P. Majumder, F. McKeon, P. W. Kantoff, W. R. Sellers, et al. p63 regulates commitment to the prostate cell lineage PNAS, August 9, 2005; 102(32): 11355 - 11360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M. Moll and N. Slade p63 and p73: Roles in Development and Tumor Formation Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Daniely, G. Liao, D. Dixon, R. I. Linnoila, A. Lori, S. H. Randell, M. Oren, and A. M. Jetten Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium Am J Physiol Cell Physiol, July 1, 2004; 287(1): C171 - C181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Westfall and J. A. Pietenpol p63: molecular complexity in development and cancer Carcinogenesis, June 1, 2004; 25(6): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. A. Moreira, P. Gromov, and J. E. Celis Expression of the Tumor Suppressor Protein 14-3-3{sigma} Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition Mol. Cell. Proteomics, April 1, 2004; 3(4): 410 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M. Moll The Role of p63 and p73 in Tumor Formation and Progression: Coming of Age Toward Clinical Usefulness: Commentary re: F. Koga et al., Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003. Clin. Cancer Res., November 15, 2003; 9(15): 5437 - 5441. [Full Text] [PDF]
|
|
|
|
|
|
F. Koga, S. Kawakami, Y. Fujii, K. Saito, Y. Ohtsuka, A. Iwai, N. Ando, T. Takizawa, Y. Kageyama, and K. Kihara Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder Clin. Cancer Res., November 15, 2003; 9(15): 5501 - 5507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Puig, P. Capodieci, M. Drobnjak, D. Verbel, C. Prives, C. Cordon-Cardo, and C. J. Di Como p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer Clin. Cancer Res., November 15, 2003; 9(15): 5642 - 5651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Langner, M. Ratschek, O. Tsybrovskyy, L. Schips, and R. Zigeuner P63 Immunoreactivity Distinguishes Upper Urinary Tract Transitional-cell Carcinoma and Renal-cell Carcinoma Even in Poorly Differentiated Tumors J. Histochem. Cytochem., August 1, 2003; 51(8): 1097 - 1099. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
